41 results about "Atomic mass unit" patented technology

Lithium ion secondary batteries are described that have high total energy, energy density and specific discharge capacity upon cycling at room temperature and at a moderate discharge rate. The improved batteries are based on high loading of positive electrode materials with high energy capacity. This capability is accomplished through the development of positive electrode active materials with very high specific energy capacity that can be loaded at high density into electrodes without sacrificing performance. The high loading of the positive electrode materials in the batteries are facilitated through using a polymer binder that has an average molecular weight higher than 800,000 atomic mass unit.

Disclosed are novel polymers derivatized with at least one —NOx group per 1200 atomic mass unit of the polymer. X is one or two. In one embodiment, the polymer is an S-nitrosylated polymer and is prepared by reacting a polythiolated polymer with a nitrosylating agent under conditions suitable for nitrosylating free thiol groups. The polymers of the present invention can be used to coat medical devices to deliver nitric oxide in vivo to treatment sites.

The present invention relates to a fragrance composition to be incorporated into the core of a core shell capsule comprising:I) 60-100% by weight of at least 5 fragrance compounds, 20-100% by weight of said fragrance compounds comprising at least 3 bulky molecules having a molecular weight of less than 325 atomic mass units, conforming to the following structures:a) molecules containing more than one ring, each ring having between 3 and 8 atoms of any of carbon, oxygen, nitrogen or sulfur in any ring and atoms being shared by any of the rings;b) molecules having at least two rings, each ring having between 3 and 8 atoms of any of carbon, oxygen, nitrogen or sulfur in which any rings share a common atom;c) molecules having at least two rings, each ring having between 3 and 8 atoms of any carbon, oxygen, nitrogen or sulfur in which any two rings share at least two adjacent common atoms;d) molecules containing a single alicyclic ring which contains at least 5 atoms, but no more than 8 atoms, of any of carbon, oxygen, nitrogen and sulfur in which at least one of the carbon atoms of the ring has two substituents, or a carbon atom alpha to the ring is tertiary carbon atom, or the ring has substituents on at least three of the atoms which make up the ring;e) molecules containing at least one macrocyclic ring, which is a ring having more greater than eight atoms of any of carbon, nitrogen oxygen or sulfur in the ring;f) molecules containing at least one substituted aromatic ring containing at least 5 atoms of any of carbon, oxygen, nitrogen or sulfur, but in which at least one substituents has a tertiary carbon in a position alpha or beta to the ring;g) molecules containing a substituted aromatic ring comprising at least 5 atoms with at least 3 substituents groups on the ring all of which must contain at least 2 atoms from among carbon, oxygen, nitrogen or sulfur; andII) 0-40% by weight of pro-fragrances, solvents, and other benefit agents which possess any of the structural features a) to g) but are not constrained by the molecular weight restrictions.

Aqueous hair cleansing and conditioning compositions are disclosed comprising comprising; a) from 1% to 50% by weight of a cleansing surfactant, b) discrete, dispersed droplets comprising a water-insoluble silicone conditioning oil characterised in that the mean diameter of the droplets (D3,2) is from 2 to 100 micrometres and c) a surface active block copolymer with a mean molecular weight of 4000 unified atomic mass units or more comprising polyethyleneoxide blocks and polypropyleneoxide blocks, wherein each block consists of 2 or more ethylene oxide or propylene oxide monomer units and wherein the mean number propylene monomer units in the block copolymer is 25 or more.

The invention provides a medical implant or medical implant part comprising porous ultrahigh molecular weight polyethylene having a weight average molecular weight of about 400,000 atomic mass units or more and a porosity of about 15% to about 65%. The invention further provides a process for producing a medical implant or medical implant part.

An implantable human kidney replacement unit. Fully functional self contained, providing patients with end stage renal disease the freedom of traveling and moving about normally. Replacing donor kidneys. Implanted in the flank with at least one inlet and outlet tube each, sutured to the iliac artery and vain, at least one urine tube to the ureter. The housing constructed of anti-coagulant bacteriostatic materials has a plurality of reverse-osmosis process chambers with semipemeable membranes through the unit, followed by osmosis-diffusion chambers and membranes. Blood from the artery enters the first of the chambers. Small molecules such as water, magnesium, sodium, potassium, calcium, urea etc. are extracted from the blood according to their weight in atomic mass units as blood wipes past the self-cleaning membrane cartridges in the chambers. Molecules are further separated and urea sent to the bladder with excess water and electrolytes. The remainder is channeled to at least one diffusion chamber and reabsorbed into the blood. The same process is repeated in the other chambers where selected larger molecules such as creatinine and phosphorus are excreted, and some diffused back into the blood.

A method for determining an expression of human epidermal growth factor receptor 2 (HER2) of a subject. The method includes providing a sample from the subject; measuring one of (i) amounts of two or more proteins in the sample, each protein having a molecular weight substantially equal to 4740, 8404, 8419, 8435, 8450, 8455, 8465, 8570, 8607 or 8626 atomic mass units, and (ii) amounts of at least one of human cystein-rich intestinal protein 1 (CRIP1), one or more variants of the human cystein-rich intestinal protein 1 (CRIP1 variants), and proteolytic digestion products thereof in the sample; and comparing the amounts of the proteins to control amounts, which control amounts are determinative of the expression of the human epidermal growth factor receptor 2.

The present invention relates to a high intensity fragrance composition for use in a cosmetic, toiletry, personal care, personal cleansing product or adsorbent article, which comprises by weight: a) 75% to 100% of at least 2 fragrance ingredients where each fragrance ingredients must contain only atoms of carbon, hydrogen, oxygen and nitrogen, comprise an ester functional group, an alcohol functional group or an aldehyde functional group, have boiling points between 100° C. and 300° C. at a pressure of 760 mm of mercury, have molecular weights within the range of 70 atomic mass units to 175 atomic mass units, and have ClogP values between 0.00 and 4.00; b) 0 to 25% of an essential oil; and c) 0 to 25% of a fragrance ingredient other than the fragrance ingredients in category a), wherein the sum of a), b) and c) equals 100%.

A method for inhibiting formation of hydrocarbon hydrates in mixtures of water and a hydrate-forming guest molecule has been discovered that involves adding a composition to the mixtures in an amount that is effective in inhibiting formation of the hydrocarbon hydrates under conditions otherwise effective to form the hydrocarbon hydrates in the absence of the reaction product. The composition includes at least one dendrimeric compound having a number average molecular weight of at least 1,000 atomic mass units (amu); and at least one small molecular weight species having less than 1,000 amu, selected from the group consisting of polyalkyleneimine, polyallylamine, starch, sugars, and polymers or copolymers of vinyl alcohol or allyl alcohol; and, optionally, at least one surfactant.

The present invention relates to a high intensity fragrance composition for use in a cosmetic, toiletry, personal care, personal cleansing product or adsorbent article, which comprises by weight: a) 75% to 100% of at least 2 fragrance ingredients where each fragrance ingredients must contain only atoms of carbon, hydrogen, oxygen and nitrogen, comprise an ester functional group, an alcohol functional group or an aldehyde functional group, have boiling points between 100° C. and 300° C. at a pressure of 760 mm of mercury, have molecular weights within the range of 70 atomic mass units to 175 atomic mass units, and have ClogP values between 0.00 and 4.00; b) 0 to 25% of an essential oil; and c) 0 to 25% of a fragrance ingredient other than the fragrance ingredients in category a), wherein the sum of a), b) and c) equals 100%.

A polyurethane foam is prepared from a reaction mixture that includes an aromatic isocyanate compound, and blowing agent, and a polyol that itself includes a poly(phenylene ether) having a number average molecular weight of 600 to 2000 atomic mass units and an average of 1.5 to 3 hydroxyl groups per molecule. Use of the poly(phenylene ether) is associated with faster formation of polyurethane, and increased compression force deflection. The polyurethane is useful for forming articles including bedding, furniture, automotive interiors, mass transportation interiors (seating, padding, instrument panels, door panels, steering wheels, armrests, and headrests), flooring underlay (foam, rebond binder), packaging, textiles, lining and gasketing applications, acoustic dampening materials, and weather stripping.

A homogeneous solid composition includes an aromatic epoxy resin and a poly(phenylene ether) having a number average molecular weight of 600 to 2000 atomic mass units and an average of 1.5 to 3 hydroxyl groups per molecule. The molecular weight and hydroxyl functionality of the poly(phenylene ether) allow it to be dissolved in the epoxy resin at relatively low temperature, and remain dissolved as the solution is cooled and solidified. The homogeneous solid composition facilitates incorporation of the poly(phenylene ether) into powder coating compositions that exhibit reduced water absorption in the cured state.

A dipeptide or tripeptide carrier system for active agent delivery to cells has an N-terminus natural amino acid and an active agent covalently bonded to a side chain of one of the remaining amino acid bases. The system is amenable to formulation as an oral administrant. The active agent being a therapeutic, a fluorescent dye, or contrast agent where the active agent has a molecular weight of less than 500 atomic mass units. An optional linker is provided intermediate between the active agent and the linking side chain.

An elemental mass spectrometer uses a mass filter to select ions from ions received from an ion source and transmit the selected ions. A reaction or collision cell receives the transmitted ions and reacts or collides these with a gas to provide product ions thereby. A mass analyzer receives the product ions, analyzes them and provides at least one output based on detection of the analyzed ions. The elemental mass spectrometer is operated to provide a first output from the mass analyzer measuring ions within a first analysis range of mass-to-charge ratios including a desired mass-to-charge ratio, M, to provide a second output from the mass analyzer measuring ions within a second analysis range of mass-to-charge ratios including a mass-to-charge ratio at least 0.95 atomic mass units lower than the desired mass-to-charge ratio, (M−i), i≧0.95 and to correct the first output on the basis of the second output.

Described here is a detector for measuring heavy mass ions with high sensitivity and low saturation for time-of-flight mass spectrometry and a detector housing for selecting between multiple detectors. It relates to sensitive measuring methods of large masses in the range of about ten thousand to a few million atomic mass units. Specifically it relates to a conversion dynode in a specifically insolated geometry followed by a discrete dynode secondary electron multiplier specifically modified to decrease electron saturation and electronic ringing. Conversion dynode detectors have been used before for time-of-flight mass spectrometry and compared to direct detection with electron multipliers they exhibit superior sensitivity for high-mass, slow-moving macromolecular ions. Using a conversion dynode specifically insolated to a common ground plane has the added capabilities of allowing an increased voltage to be applied to the conversion dynode while maintaining a minimum distance between the conversion dynode and the front of the electron multiplier. This creates faster ion flight time for the secondary ions produced within the detector allowing for higher time resolution and sensitivity from the detector. Also, by adding capacitance as charge buffers to the last few electrodes of a discrete dynode electron multiplier used as a secondary electron multiplier, saturation can be greatly reduced or avoided, which is often a major problem when measuring samples with ions covering a broad mass range. The detector housing described allows multiple detectors to be selected without breaking the vacuum. By keeping all moving mechanical parts inside the vacuum, a more simple, robust and cost effective design can be realized which provides a platform for measuring ions using different detector designs.

A polyurethane or polyisocyanurate foam is prepared from a reaction mixture that includes comprising a polyol, an aromatic isocyanate compound, and a blowing agent. The polyol includes a poly(phenylene ether) having a number average molecular weight of 600 to 2000 atomic mass units and an average of 1.5 to 3 hydroxyl groups per molecule. The polyurethane or polyisocyanurate foam exhibits improved resistance to burning and / or reduced elapsed times to formation of tack-free foams relative to foams prepared without the poly(phenylene ether).

A method for determining an expression of human epidermal growth factor receptor 2 (HER2) of a subject. The method includes providing a sample from the subject; measuring one of (i) amounts of two or more proteins in the sample, each protein having a molecular weight substantially equal to 4740, 8404, 8419, 8435, 8450, 8455, 8465, 8570, 8607 or 8626 atomic mass units, and (ii) amounts of at least one of human cystein-rich intestinal protein 1 (CRIP1), one or more variants of the human cystein-rich intestinal protein 1 (CRIP1 variants), and proteolytic digestion products thereof in the sample; and comparing the amounts of the proteins to control amounts, which control amounts are determinative of the expression of the human epidermal growth factor receptor 2.

The invention provides a polyurethane foam and associated method and article. The polyurethane foam is prepared from a reaction mixture that includes an aromatic isocyanate compound, and blowing agent, and a polyol that itself includes a poly(phenylene ether) having a number average molecular weight of 600 to 2000 atomic mass units and an average of 1.5 to 3 hydroxyl groups per molecule. Use of the poly(phenylene ether) is associated with faster formation of polyurethane, and increased compression force deflection. The polyurethane is useful for forming articles including bedding, furniture, automotive interiors, mass transportation interiors (seating, padding, instrument panels, door panels, steering wheels, armrests, and headrests), flooring underlay (foam, rebond binder), packaging, textiles, lining and gasketing applications, acoustic dampening materials, and weather stripping.

A poly(phenylene ether) copolymer comprising about 5 to 40 mole percent repeat units derived from 2-phenylphenol and 60 to about 95 mole percent repeat units derived from 2,6-dimethylphenol, wherein the poly(phenylene ether) copolymer has a weight average molecular weight of at least 8,000 atomic mass units, is disclosed. Also disclosed is a method of preparing the poly(phenylene ether) copolymer, the method comprising oxidatively copolymerizing a monomer mixture comprising about 5 to 40 mole percent 2-phenylphenol and about 60 to about 95 mole percent 2,6-dimethylphenol in the presence of a solvent, molecular oxygen, and a polymerization catalyst comprising a metal ion and at least one amine ligand to form a solution of the poly(phenylene ether) copolymer in the solvent, wherein a ratio of total moles of 2-phenylphenol and 2,6-dimethylphenol to moles of metal ion is about 10:1 to about 1200:1.

A composition adapted for mass spectral analysis is disclosed as are methods of its use in mass spectral analyses. A contemplated composition contains a mass spectrally-determinable amount of each of (i) at least one analyte to be assayed and (ii) a standard compound. Each of the molecules of the standard compound contains one or the other of a pair of two stable isotopes of the same element that differ in molecular weight by at least two atomic mass units. Those two isotopes are present in the molecules of the standard compound in a predetermined ratio that is other than the naturally occurring ratio of those isotopes.